1-1 of 1
Sylvia Lucas, M.D., Ph.D.
Close
Sort by
Journal Articles

Hematopoietic Stem/Progenitor Cells (HSPC) Mobilization Parameters in Patients Chronically Treated with the CD49d Blocking Antibody Natalizumab.

Halvard Bonig, MD, Annette Wundes, M.D., Kai-Hsin Chang, Ph.D., Sylvia Lucas, M.D., Ph.D., Thalia Papayannopoulou, M.D.
Journal: Blood
Blood (2007) 110 (11): 177.
https://doi.org/10.1182/blood.V110.11.177.177
Published: 2007